Isolated focal cortical dysplasia type II: genes and variants
Explore variant evidence for Isolated focal cortical dysplasia type II across 4 analyzed proteins (MTOR, TSC2, RHEB, TSC1). Linked ClinVar records include 12 pathogenic or likely pathogenic variants, 275 variants of uncertain significance and 130 with conflicting classifications.
Coverage includes proteins already analyzed in CATVariant, not every gene involved in this condition. Database links are associations, not an assessment of clinical gene–disease validity. Computable evidence prioritizes variants for expert review and does not reclassify them. Source labels are pooled across this disease family.
Data updated 2026-11-04. Automated aggregation, not a clinical review date.
Download variant evidence (CSV)
Genes linked to Isolated focal cortical dysplasia type II
MTOR: Serine/threonine-protein kinase mTOR
It integrates nutrient, energy, oxygen, and growth-factor signals to control protein synthesis, autophagy, metabolism, and cell growth. Activating germline or mosaic variants can cause developmental brain overgrowth and epilepsy, while persistent pathway activation is common in cancer.
9 ClinVar pathogenic / likely pathogenic and 16 uncertain variants in MTOR have source records linked to Isolated focal cortical dysplasia type II. Association strength is not clinical gene validity.
TSC2: Tuberin
Together with TSC1, it inactivates RHEB and restrains mTORC1 when growth conditions are unfavorable. Loss-of-function variants cause tuberous sclerosis complex with hamartomas and tumors affecting the brain, kidneys, skin, heart, lungs, and other organs.
2 ClinVar pathogenic / likely pathogenic and 169 uncertain variants in TSC2 have source records linked to Isolated focal cortical dysplasia type II. Association strength is not clinical gene validity.
RHEB: GTP-binding protein Rheb
Its GTP-bound form directly activates mTORC1 in response to growth and nutrient signals and is normally restrained by the TSC1-TSC2 complex. Activating variants can cause neurodevelopmental overgrowth and epilepsy phenotypes through excessive mTOR signaling.
1 ClinVar pathogenic / likely pathogenic and 0 uncertain variants in RHEB have source records linked to Isolated focal cortical dysplasia type II. Association strength is not clinical gene validity.
TSC1: Hamartin
Together with TSC2, it restrains RHEB and mTORC1 signaling, preventing inappropriate cell growth when nutrients or growth signals are limited. Loss-of-function variants cause tuberous sclerosis complex with hamartomas and tumors in the brain, kidney, skin, heart, lungs, and other organs.
0 ClinVar pathogenic / likely pathogenic and 219 uncertain variants in TSC1 have source records linked to Isolated focal cortical dysplasia type II. Association strength is not clinical gene validity.
Weakly linked (only a few uncertain records): NTHL1.
Where Isolated focal cortical dysplasia type II variants cluster
- MTOR TPR 4 (positions 1443–1473): 4 of 9 ClinVar pathogenic / likely pathogenic variants, 36.5× more than its size predicts (a length-based count, not a validated hotspot).
ClinVar pathogenic and likely pathogenic variants linked to Isolated focal cortical dysplasia type II
| Variant | Position | Protein part | Clinical label |
|---|---|---|---|
| MTOR A1459D | 1459 | FAT | Pathogenic / likely pathogenic (★★) |
| RHEB Y35L | 35 | Effector region | Pathogenic / likely pathogenic (★★) |
| TSC2 H1746P | 1746 | Rap-GAP | Pathogenic / likely pathogenic (★★) |
| MTOR E1799K | 1799 | FAT | Pathogenic / likely pathogenic (★★) |
| MTOR A1459P | 1459 | FAT | Pathogenic / likely pathogenic (★) |
| MTOR L2427R | 2427 | PI3K/PI4K catalytic | Pathogenic / likely pathogenic (★) |
| TSC2 R622P | 622 | Pathogenic / likely pathogenic (★) | |
| MTOR L1433S | 1433 | FAT | Pathogenic / likely pathogenic (★) |
| MTOR Y1450D | 1450 | FAT | Pathogenic / likely pathogenic (★) |
| MTOR I1973F | 1973 | FAT | Pathogenic / likely pathogenic (★) |
| MTOR W1456G | 1456 | FAT | Pathogenic / likely pathogenic |
| MTOR L2427Q | 2427 | PI3K/PI4K catalytic | Pathogenic / likely pathogenic |
Which prediction tools work for Isolated focal cortical dysplasia type II
Observed separation of ClinVar pathogenic / likely pathogenic from benign / likely benign variants (AUROC × 100). This benchmark is not a clinical recommendation.
- CATVariant: 97 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- AlphaMissense: 97 out of 100
- ESM1b (LLR): 96 out of 100
- PolyPhen-2: 78 out of 100 (learned from overlapping clinical labels, so this is optimistic)
Same protein, different disease
- Macrocephaly-intellectual disability-neurodevelopmental disorder-small thorax syndrome also has ClinVar records linked to MTOR variants; they fall mostly in different places as the Isolated focal cortical dysplasia type II variants (13 pathogenic / likely pathogenic).
- Overgrowth syndrome and/or cerebral malformations due to abnormalities in MTOR pathway genes also has ClinVar records linked to MTOR variants; they fall mostly in different places as the Isolated focal cortical dysplasia type II variants (12 pathogenic / likely pathogenic).
- CEBALID syndrome also has ClinVar records linked to MTOR variants; they fall mostly in different places as the Isolated focal cortical dysplasia type II variants (6 pathogenic / likely pathogenic).
- Tuberous sclerosis also has ClinVar records linked to TSC2 variants; they fall mostly in different places as the Isolated focal cortical dysplasia type II variants (59 pathogenic / likely pathogenic).
- Ovarian cancer also has ClinVar records linked to TSC2 variants; they fall mostly in different places as the Isolated focal cortical dysplasia type II variants (4 pathogenic / likely pathogenic).
Diseases related to Isolated focal cortical dysplasia type II
- Tuberous sclerosis, also linked to TSC1 and TSC2
- Ovarian cancer, also linked to TSC1 and TSC2
- Lymphangiomyomatosis, also linked to TSC1 and TSC2
- Familial adenomatous polyposis, also linked to TSC2
- Urinary bladder cancer, also linked to TSC1
- Overgrowth syndrome and/or cerebral malformations due to abnormalities in MTOR pathway genes, also linked to MTOR
- Macrocephaly-intellectual disability-neurodevelopmental disorder-small thorax syndrome, also linked to MTOR
- CEBALID syndrome, also linked to MTOR
- Hepatocellular carcinoma, also linked to TSC2
Frequently asked questions
Which genes have records linked to Isolated focal cortical dysplasia type II?
This view contains 4 analyzed proteins: MTOR, TSC2, RHEB, TSC1. Links come from clinical records and association databases. They do not imply that every listed gene is a validated cause, and missing genes may not yet be analyzed.
What do the clinical classifications mean?
Linked records include 12 pathogenic or likely pathogenic variants, 275 variants of uncertain significance and 130 with conflicting classifications. Labels summarize source records; multi-condition records may not make a separate assertion for this disease. Check the original record and review status.
Does the evidence score change a VUS classification?
No. 0 VUS or conflicting variants reach the likely-pathogenic points range on the computable criteria available here. This is a research prioritization signal, not a clinical classification. Patient, family and other required evidence may be missing.
Can I download the variant evidence?
Download the CSV for all 448 variants in the selected disease scope, including clinical labels, review status, evidence criteria, predictor scores, functional measurements and population frequency where available.
About this data
Variant–disease links come from ClinVar, Open Targets and UniProt, pooled from eligible public CATVariant analyses of each human protein. Evidence scores use the ACMG/AMP Bayesian points scale with computable criteria only (position among known disease variants, rarity in gnomAD, calibrated predictors, deep mutational scanning); there is no family or patient data, so they prioritise variants for expert review and never classify them.
Download every variant as CSV · Browse all diseases · Methods · About the Center